Add news
March 2010
April 2010
May 2010June 2010July 2010
August 2010
September 2010October 2010
November 2010
December 2010
January 2011
February 2011March 2011April 2011May 2011June 2011July 2011August 2011September 2011October 2011November 2011December 2011January 2012February 2012March 2012April 2012May 2012June 2012July 2012August 2012September 2012October 2012November 2012December 2012January 2013February 2013March 2013April 2013May 2013June 2013July 2013August 2013September 2013October 2013November 2013December 2013January 2014February 2014March 2014April 2014May 2014June 2014July 2014August 2014September 2014October 2014November 2014December 2014January 2015February 2015March 2015April 2015May 2015June 2015July 2015August 2015September 2015October 2015November 2015December 2015January 2016February 2016March 2016April 2016May 2016June 2016July 2016August 2016September 2016October 2016November 2016December 2016January 2017February 2017March 2017April 2017May 2017June 2017July 2017August 2017September 2017October 2017November 2017December 2017January 2018February 2018March 2018April 2018May 2018June 2018July 2018August 2018September 2018October 2018November 2018December 2018January 2019February 2019March 2019April 2019May 2019June 2019July 2019August 2019September 2019October 2019November 2019December 2019January 2020February 2020March 2020April 2020May 2020June 2020July 2020August 2020September 2020
News Every Day |

Hahn: AstraZeneca's COVID-19 vaccine trial is still on hold in the U.S.

AstraZeneca's Phase 3 trial for its COVID-19 vaccine candidate is still on hold in the U.S., according to remarks made Tuesday by Food and Drug Administration commissioner Dr. Stephen Hahn during an Instagram Live with Sen. Tim Scott (R-S.C.). Shares of AstraZeneca were up 1.1% in premarket trading on Wednesday morning. Hahn said the FDA is working with the drug maker "to figure out if there's a significant safety issue or not" after the company confirmed last week that it had halted its trial in the U.K. after a participant reported a "potentially unexplained illness." (The New York Times reported that the illness is transverse myelitis, a rare spinal disorder sometimes associated with vaccines.) "If a serious adverse event occurs, that's a trigger to stop the trial so that we can pause - it's really a pause, not a stop - and we can take a look at that," Hahn said. AstraZeneca's stock so far this year has gained 10.6%, while the S&P 500 is up 5.2%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit for more information on this news.

Read also

Donald Trump’s married son Eric says he is member of the LGBT community

Calls Increase for Ban on Scandinavian Neo-Nazi Group After Synagogues Targeted by Hateful Propaganda on Yom Kippur

Troy Police Dispatcher Dies After On Duty Heart Attack

News, articles, comments, with a minute-by-minute update, now on — latest news 24/7. You can add your news instantly now — here